About MEDIFAST INC
Ticker
info
MED
Trading on
info
NYSE
ISIN
info
US58470H1014
Industry
info
Personal Services
Sector
info
Consumer Cyclical
CEO
info
Nicholas M. Johnson
Headquarters
info
1501 S. Clinton Street, Baltimore, MD, United States, 21224
Employees
info
380
Website
info
https://medifastinc.com
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.
Metrics
BasicAdvanced
Market cap
info
$128M
P/E ratio
info
-
EPS
info
-$2.33
Dividend Yield
info
0.00%
Beta
info
0.7
Forward P/E ratio
info
12.48
EBIDTA
info
$-5.7M
Ex dividend date
info
2023-09-18
Price & volume
Market cap
info
$128M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
12.48
PEG ratio
info
0.97
Trailing P/E
info
0
Price to sales
info
0.41
Price to book
info
0.69
Earnings
EPS
info
-$2.33
EPS estimate (current quarter)
info
-$0.65
EPS estimate (next quarter)
info
-$0.62
EBITDA
info
$-5.7M
Revenues (TTM)
info
$317M
Revenues per share (TTM)
info
$28.73
Technicals
Beta
info
0.7
52-week High
info
$14.67
52-week Low
info
$9.22
50-day moving average
info
$11.02
200-day moving average
info
$11.17
Short ratio
info
8.84
Short %
info
13.75%
Management effectiveness
ROE (TTM)
info
-12.42%
ROA (TTM)
info
-4.60%
Profit margin
info
-8.08%
Gross profit margin
info
$219M
Operating margin
info
-5.66%
Growth
Quarterly earnings growth (YoY)
info
-87.20%
Quarterly revenue growth (YoY)
info
-27.60%
Share stats
Outstanding Shares
info
11.2M
Float
info
7.8M
Insiders %
info
4.17%
Institutions %
info
78.36%
Analyst Insights & forecasts
info

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$12.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.21
-$0.36
41.67%
Q3 • 25Beat
-$1.65
-$0.45
-266.67%
Q4 • 25Missed
-$0.19
-$0.52
63.46%
Q1 • 26Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$76M
$-2.1M
-2.79%
Q1 • 26
$76.4M
$-3.1M
-4.06%
Q2 • 26
0.45%
46.09%
45.44%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$252M
$54.4M
21.57%
Q1 • 26
$260M
$64M
24.59%
Q2 • 26
3.31%
17.77%
13.99%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$0.3M
$-19.7M
$-0.9M
$-0.8M
Q1 • 26
$1.7M
$-0.3M
$-0.1M
$0.7M
Q2 • 26
552.69%
-98.66%
-90.79%
-187.08%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a MEDIFAST INC share?
Collapse

MEDIFAST INC shares are currently traded for undefined per share.

How many shares does MEDIFAST INC have?
Collapse

MEDIFAST INC currently has 11.2M shares.

Does MEDIFAST INC pay dividends?
Collapse

No, MEDIFAST INC doesn't pay dividends.

What is MEDIFAST INC 52 week high?
Collapse

MEDIFAST INC 52 week high is $14.67.

What is MEDIFAST INC 52 week low?
Collapse

MEDIFAST INC 52 week low is $9.22.

What is the 200-day moving average of MEDIFAST INC?
Collapse

MEDIFAST INC 200-day moving average is $11.17.

Who is MEDIFAST INC CEO?
Collapse

The CEO of MEDIFAST INC is Nicholas M. Johnson.

How many employees MEDIFAST INC has?
Collapse

MEDIFAST INC has 380 employees.

What is the market cap of MEDIFAST INC?
Collapse

The market cap of MEDIFAST INC is $128M.

What is the P/E of MEDIFAST INC?
Collapse

The current P/E of MEDIFAST INC is null.

What is the EPS of MEDIFAST INC?
Collapse

The EPS of MEDIFAST INC is -$2.33.

What is the PEG Ratio of MEDIFAST INC?
Collapse

The PEG Ratio of MEDIFAST INC is 0.97.

What do analysts say about MEDIFAST INC?
Collapse

According to the analysts MEDIFAST INC is considered a hold.